We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
+8.54%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$210M
AUM Growth
+$9.98M
(+5%)
Cap. Flow
+$2.18M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
30.25%
Holding
124
New
24
Increased
26
Reduced
38
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kura Oncology
KURA
|
+$3.88M |
| 2 |
Adtran
ADTN
|
+$2.69M |
| 3 |
MaxLinear
MXL
|
+$2.38M |
| 4 |
GXO Logistics
GXO
|
+$1.98M |
| 5 |
Sportradar
SRAD
|
+$1.89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$5.64M |
| 2 |
Carpenter Technology
CRS
|
+$3.28M |
| 3 |
GTLS
Chart Industries
GTLS
|
+$2.82M |
| 4 |
Grid Dynamics Holdings
GDYN
|
+$2.34M |
| 5 |
VRNA
Verona Pharma
VRNA
|
+$2.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.8% |
| 2 | Industrials | 19.67% |
| 3 | Healthcare | 18.04% |
| 4 | Financials | 15.4% |
| 5 | Consumer Discretionary | 8.87% |
Similar funds
KA
LCGC
DEA
EAN
PIP
VIG
SC
L
1492 Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, 1492 Capital Management held 124 positions worth $210M, up 5% from $200M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
1492 Capital Management's Q4 2024 filing shows 24 new, 26 increased, 38 reduced and 15 closed positions. Its largest new stake was Adtran: 364,056 shares worth $3.03M. The largest sale was Exact Sciences, an estimated $5.64M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.
- 1492 Capital Management's largest Q4 2024 buy was Adtran: 364,056 shares worth $3.03M.
- 1492 Capital Management added most to Kura Oncology in Q4 2024, an estimated $3.88M increase.
- 1492 Capital Management's biggest Q4 2024 reduction was Carpenter Technology, cutting an estimated $3.28M.
- 1492 Capital Management fully exited Exact Sciences in Q4 2024, selling an estimated $5.64M.
- 1492 Capital Management's ten largest holdings make up 30% of its $210M portfolio in Q4 2024.
- 1492 Capital Management opened 24 new positions and closed 15 in Q4 2024.
- 1492 Capital Management's portfolio value rose 5% quarter-over-quarter to $210M.
Based on 1492 Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.